Literature DB >> 51031

Stimulation of human neutrophils by soluble and insoluble immunoglobulin aggregates. Secretion of granule constituents and increased oxidation of glucose.

P M Henson, Z G Oades.   

Abstract

Reaction of human neutrophils with aggregated immunoglobulin on nonphagocytosable surfaces results in secretion of granule enzymes (exocytosis of granules) and stimulation of glucose oxidation by the nexose monophosphate pathway (HMP). The role of HMP stimulation in the enzyme secretion and some requirements for the two neutrophil activities have been examined. It was found that (a) HMP stimulation could be selectively inhibited under conditions where release of granule enzymes remained unchanged or was enhanced, for example, by reduced glucose concentration or by 2-deoxyglucose. (b) Removal of Ca++ and addition of agents which increased the intracellular levels of cyclic AMP (cAMP), however, prevented both activities, while colchicine had greater inhibitory activity on HMP stimulation than upon secretion. (c) Neutrophils incubated in suspension with particulate aggregated gamma-globulin phagocytosed the particles and exhibited a stimulated HMP and released granule enzymes. In contrast, incubation in suspension with soluble aggregated gamma-globulin resulted in the stimulated HMP only. Granule evzymes were not liberated. 300-fold less soluble aggregates bound to a surface, however readily induced exocytosis of granules from adherent neutrophils. This demonstrates the importance of surface effects in the induction of secretion from neutrophils. Aggregated immunoglobulin reacting with neutrophil Fc receptors thus induces both degranulation (exocytosis) and increased HMP activity. The pathways leading to these events are separable although apparently sharing some common steps, including the initiating events.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 51031      PMCID: PMC301961          DOI: 10.1172/JCI108152

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Occurrence and control of the phosphogluconate oxidation pathway in normal and leukemic leukocytes.

Authors:  W S BECK
Journal:  J Biol Chem       Date:  1958-05       Impact factor: 5.157

2.  The immunologic release of constituents from neutrophil leukocytes. II. Mechanisms of release during phagocytosis, and adherence to nonphagocytosable surfaces.

Authors:  P M Henson
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

3.  The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles.

Authors:  P M Henson
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

4.  Mechanisms of phagocytosis in human polymorphonuclear leucocytes.

Authors:  T D Brogan
Journal:  Immunology       Date:  1966-02       Impact factor: 7.397

5.  Phagocytosis by human blood leucocytes during suppression of glycolysis.

Authors:  P Bodel; S E Malawista
Journal:  Exp Cell Res       Date:  1969-07       Impact factor: 3.905

6.  Mechanisms of lysosomal enzyme release from leukocytes exposed to immune complexes and other particles.

Authors:  G Weissmann; R B Zurier; P J Spieler; I M Goldstein
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

7.  Biopolymer membrane: a model system for the study of the neutrophilic leukocyte response to immune complexes.

Authors:  D Hawkins
Journal:  J Immunol       Date:  1971-08       Impact factor: 5.422

8.  Stimulation of human neutrophil leukocyte aerobic glucose metabolism by purified chemotactic factors.

Authors:  E J Goetzl; K F Austen
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

9.  The dissociation by colchicine of phagocytosis from increased oxygen consumption in human leukocytes.

Authors:  S E Malawista; P T Bodel
Journal:  J Clin Invest       Date:  1967-05       Impact factor: 14.808

10.  Cyclic 3',5'-adenosine monophosphate in the human lukocyte: synthesis, degradation, andeffects n neutrophil candidacidal activity.

Authors:  H R Bourne; R I Lehrer; M J Cline; K L Melmon
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

View more
  75 in total

1.  Human neutrophil formyl peptide receptor phosphorylation and the mucosal inflammatory response.

Authors:  Giovanna Leoni; Jeannie Gripentrog; Connie Lord; Marcia Riesselman; Ronen Sumagin; Charles A Parkos; Asma Nusrat; Algirdas J Jesaitis
Journal:  J Leukoc Biol       Date:  2014-11-13       Impact factor: 4.962

2.  The specificity of the IgA receptor purified from human neutrophils.

Authors:  R L Mazengera; M A Kerr
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

3.  Rapid micromeasurement of neutrophil exocytosis.

Authors:  R O Webster; P M Henson
Journal:  Inflammation       Date:  1978-06       Impact factor: 4.092

4.  In vitro activation of rat neutrophils and alveolar macrophages with IgA and IgG immune complexes. Implications for immune complex-induced lung injury.

Authors:  J S Warren; S L Kunkel; K J Johnson; P A Ward
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

5.  Preparation of secretory vesicle-free plasma membranes by isopycnic sucrose gradient fractionation of neutrophils purified by the gelatin method.

Authors:  Jamal Stie; Algirdas J Jesaitis
Journal:  Cytotechnology       Date:  2005-11-30       Impact factor: 2.058

6.  Elaboration of toxic oxygen by-products by neutrophils in a model of immune complex disease.

Authors:  R B Johnston; J E Lehmeyer
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

7.  Requirement of the Shigella flexneri virulence plasmid in the ability to induce trafficking of neutrophils across polarized monolayers of the intestinal epithelium.

Authors:  B A McCormick; A M Siber; A T Maurelli
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Inhibition of neutrophil migration by sera from patients with rheumatoid arthritis.

Authors:  A S Kemp; P Roberts-Thomson; S H Neoh; S Brown
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

9.  Assessment of the efficacy of polyclonal intravenous immunoglobulin G (IVIG) against the infectivity of clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo.

Authors:  N Farag; L Mahran; K Abou-Aisha; M El-Azizi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-03-27       Impact factor: 3.267

10.  Molecular cloning and preliminary characterization of a novel cytoplasmic antigen recognized by myasthenia gravis sera.

Authors:  T Gordon; B Grove; J C Loftus; T O'Toole; R McMillan; J Lindstrom; M H Ginsberg
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.